JP2014517028A5 - - Google Patents

Info

Publication number
JP2014517028A5
JP2014517028A5 JP2014515299A JP2014515299A JP2014517028A5 JP 2014517028 A5 JP2014517028 A5 JP 2014517028A5 JP 2014515299 A JP2014515299 A JP 2014515299A JP 2014515299 A JP2014515299 A JP 2014515299A JP 2014517028 A5 JP2014517028 A5 JP 2014517028A5
Authority
JP
Japan
Prior art keywords
composition
oil
emulsion
drug
triglycerides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014515299A
Other languages
English (en)
Japanese (ja)
Other versions
JP5864735B2 (ja
JP2014517028A (ja
Filing date
Publication date
Priority claimed from US13/161,101 external-priority patent/US8895074B2/en
Application filed filed Critical
Priority claimed from PCT/IB2012/001156 external-priority patent/WO2012172411A1/en
Publication of JP2014517028A publication Critical patent/JP2014517028A/ja
Publication of JP2014517028A5 publication Critical patent/JP2014517028A5/ja
Application granted granted Critical
Publication of JP5864735B2 publication Critical patent/JP5864735B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014515299A 2011-06-15 2012-06-13 非経口オキアミ油の治療用途 Expired - Fee Related JP5864735B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13/161,101 2011-06-15
US13/161,101 US8895074B2 (en) 2011-06-15 2011-06-15 Therapeutic application of parenteral krill oil
EP11179821.1 2011-09-02
EP11179821 2011-09-02
PCT/IB2012/001156 WO2012172411A1 (en) 2011-06-15 2012-06-13 Therapeutic application of parenteral krill oil

Publications (3)

Publication Number Publication Date
JP2014517028A JP2014517028A (ja) 2014-07-17
JP2014517028A5 true JP2014517028A5 (enExample) 2015-07-30
JP5864735B2 JP5864735B2 (ja) 2016-02-17

Family

ID=46456944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014515299A Expired - Fee Related JP5864735B2 (ja) 2011-06-15 2012-06-13 非経口オキアミ油の治療用途

Country Status (22)

Country Link
EP (1) EP2720701B1 (enExample)
JP (1) JP5864735B2 (enExample)
KR (1) KR101841588B1 (enExample)
CN (2) CN107648268B (enExample)
BR (1) BR112013032224B1 (enExample)
CA (1) CA2838312C (enExample)
CY (1) CY1119417T1 (enExample)
DK (1) DK2720701T3 (enExample)
ES (1) ES2643843T3 (enExample)
HR (1) HRP20171431T1 (enExample)
HU (1) HUE036720T2 (enExample)
IL (1) IL229690A (enExample)
LT (1) LT2720701T (enExample)
MX (1) MX351895B (enExample)
PL (1) PL2720701T3 (enExample)
PT (1) PT2720701T (enExample)
RS (1) RS56394B1 (enExample)
RU (1) RU2625760C2 (enExample)
SI (1) SI2720701T1 (enExample)
SM (1) SMT201700470T1 (enExample)
TW (1) TWI592160B (enExample)
WO (1) WO2012172411A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2993980B1 (en) 2013-05-10 2023-11-01 Memorial Sloan Kettering Cancer Center Lipid scavenging in ras cancers
GB201402457D0 (en) 2014-02-12 2014-03-26 Aker Biomarine As Capsules containing high doses of phospholipids
GB201402450D0 (en) 2014-02-12 2014-03-26 Aker Biomarine As Liquid phospholipid-containing compositions for preperation of pharmaceuticals
GB201407345D0 (en) 2014-04-25 2014-06-11 Aker Biomarine As Krill Phospholipid compositions
PL3137070T3 (pl) * 2014-04-30 2020-07-13 Aker Biomarine Antarctic As Preparaty z oleju z kryla i ich zastosowania
EP3232798A1 (en) 2014-12-19 2017-10-25 Aker Biomarine Antarctic AS Enhanced omega-3 formulations
JP6814148B2 (ja) * 2015-03-31 2021-01-13 フレゼニウス カービ ドイチュラント ゲーエムベーハー 非経口投与用のエマルション
CN105901740A (zh) * 2016-04-26 2016-08-31 济南极源生物科技有限公司 一种南极磷虾油可食用营养品
CN118000419A (zh) * 2017-08-10 2024-05-10 儿童医疗中心有限公司 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物
EP3536332A1 (en) * 2018-03-07 2019-09-11 Athenion AG Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
KR102451162B1 (ko) * 2020-09-07 2022-10-06 (주)에스디생명공학 효소처리 크릴 오일 추출물을 유효성분으로 포함하는 항염증, 피부 주름개선, 보습 및 피부 재생 촉진용 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
JPH08231391A (ja) * 1995-02-24 1996-09-10 Kanagawa Kagaku Kenkyusho:Kk 痴呆症状改善薬
ATE497384T1 (de) * 1997-12-10 2011-02-15 Cyclosporine Therapeutics Ltd Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
GB0012597D0 (en) * 2000-05-25 2000-07-12 Astrazeneca Ab Formulation
DK1997498T3 (da) * 2001-06-18 2012-07-30 Neptune Technologies & Bioressources Inc Krillekstrakter til forebyggelse og/eller behandling af kardiovaskulære sygdomme
US7666447B2 (en) 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
CN101321477A (zh) * 2005-10-07 2008-12-10 加拿大海洋营养食品有限公司 脂肪酸盐及其制备和使用方法
CL2007003283A1 (es) * 2006-11-16 2008-05-23 Pronova Biopharma Norge As Proceso para extraer una fraccion casi total de lipidos a partir del krill fresco que comprende reducir el contenido de agua de la materia prima y aislar la fraccion de lipidos; fraccion casi total de lipidos; proceso para separar fosfolipidos; fracc
WO2008117062A1 (en) 2007-03-28 2008-10-02 Aker Biomarine Asa Bioeffective krill oil compositions
JP5443979B2 (ja) * 2007-05-11 2014-03-19 備前化成株式会社 新規のロイコトリエン受容体アンタゴニスト
NO327925B1 (no) * 2007-06-25 2009-10-19 Pharmalogica As Anvendelse av kullsyre i drikker omfattende polyumettede fettsyrer (PUFA) for a hindre oksidasjon av fettsyrene.
US20090099261A1 (en) * 2007-09-25 2009-04-16 Isi Brands Inc. Omega-3 mixtures
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
US20100130619A1 (en) * 2008-11-24 2010-05-27 Joseph Schwarz Pharmaceutical composition for parenteral administration of idebenone
US8241672B2 (en) 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
NO333013B1 (no) * 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
US8609157B2 (en) * 2009-10-30 2013-12-17 Tharos Ltd. Solvent-free process for obtaining phospholipids and neutral enriched krill oils

Similar Documents

Publication Publication Date Title
JP2014517028A5 (enExample)
RU2014138996A (ru) Гормонсодержащая эмульсия
ES2768091T3 (es) Uso del éster etílico del ácido eicosapentaenoico para tratar la hipertrigliceridemia
Nicholson et al. The role of marine n-3 fatty acids in improving cardiovascular health: a review
JP5864735B2 (ja) 非経口オキアミ油の治療用途
Ceylan et al. Wheat germ oil nanoemulsion for oil stability of the cooked fish fillets stored at 4 C
RU2011141102A (ru) Обогащенные омега-3 рыбные парентеральные питательные эмульсии типа масло в воде
PT2144618E (pt) Composições bioeficazes de óleo de krill
US20070122452A1 (en) Fat composition
BR112014016788A2 (pt) composições de ácidos graxos poli-insaturados ômega-3 em forma de ácido livre, enriquecidas com dpa
JP2013508296A5 (enExample)
Badiu et al. Effect of olive oil on the skin
JP2014505702A5 (enExample)
FI3664628T3 (fi) Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia
WO2011137160A3 (en) Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans
RU2016129079A (ru) Композиции омега-3 жирных кислот для лечения заболеваний, вызывающих поражение нервной системы
Kindernay et al. Beneficial Effects of Polyphenol-Rich Food Oils in Cardiovascular Health and Disease
DK2768316T3 (en) LIPID COMPOSITION FOR PREVENTION OR TREATMENT OF SKIN PROBLEMS
RU2016116835A (ru) Способы и композиции для улучшения функции почек
Wei et al. The potential of marine oils as functional foods: Nutritional composition, health benefits, applications, and future perspectives
WO2015050071A1 (ja) 栄養補助剤及び心血管疾患改善剤
DiNicolantonio et al. Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter?
Jarreau et al. Should we start prescribing omega-3 polyunsaturated fatty acids in chronic heart failure?
Crawford Another Supplement for CAD Prevention Fails
JP6519875B2 (ja) 改良された魚油ベースのオメガ3補助食品